1. Home
  2. SER vs ABLV Comparison

SER vs ABLV Comparison

Compare SER & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SER
  • ABLV
  • Stock Information
  • Founded
  • SER 2017
  • ABLV 2015
  • Country
  • SER United States
  • ABLV China
  • Employees
  • SER N/A
  • ABLV N/A
  • Industry
  • SER Biotechnology: Pharmaceutical Preparations
  • ABLV
  • Sector
  • SER Health Care
  • ABLV
  • Exchange
  • SER Nasdaq
  • ABLV Nasdaq
  • Market Cap
  • SER 46.7M
  • ABLV 38.1M
  • IPO Year
  • SER 2018
  • ABLV N/A
  • Fundamental
  • Price
  • SER $6.13
  • ABLV $0.65
  • Analyst Decision
  • SER
  • ABLV
  • Analyst Count
  • SER 0
  • ABLV 0
  • Target Price
  • SER N/A
  • ABLV N/A
  • AVG Volume (30 Days)
  • SER 37.9K
  • ABLV 18.1K
  • Earning Date
  • SER 11-12-2024
  • ABLV 01-01-0001
  • Dividend Yield
  • SER N/A
  • ABLV N/A
  • EPS Growth
  • SER N/A
  • ABLV 18.07
  • EPS
  • SER N/A
  • ABLV 0.24
  • Revenue
  • SER $3,157,500.00
  • ABLV $148,999,819.00
  • Revenue This Year
  • SER N/A
  • ABLV N/A
  • Revenue Next Year
  • SER N/A
  • ABLV N/A
  • P/E Ratio
  • SER N/A
  • ABLV $3.07
  • Revenue Growth
  • SER 2454.55
  • ABLV 2.58
  • 52 Week Low
  • SER $3.81
  • ABLV $0.55
  • 52 Week High
  • SER $23.18
  • ABLV $3.94
  • Technical
  • Relative Strength Index (RSI)
  • SER 58.82
  • ABLV 45.41
  • Support Level
  • SER $4.15
  • ABLV $0.55
  • Resistance Level
  • SER $6.24
  • ABLV $0.77
  • Average True Range (ATR)
  • SER 0.73
  • ABLV 0.07
  • MACD
  • SER 0.08
  • ABLV -0.01
  • Stochastic Oscillator
  • SER 84.62
  • ABLV 48.83

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

About ABLV Able View Global Inc.

Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.

Share on Social Networks: